+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
US Lymphedema Treatment Market Forecast to 2028 - Country Analysis By Condition Type, Treatment Type, and End User- Product Image
US Lymphedema Treatment Market Forecast to 2028 - Country Analysis By Condition Type, Treatment Type, and End User- Product Image
Sale

US Lymphedema Treatment Market Forecast to 2028 - Country Analysis By Condition Type, Treatment Type, and End User

  • PDF Icon

    Report

  • 132 Pages
  • May 2023
  • Region: United States
  • The Insight Partners
  • ID: 5806753
UP TO OFF until Jun 30th 2024
Description Jump to:
The US lymphedema treatment market size is expected to grow from US$ 5,185.98 million in 2022 to US$ 8,320.07 million by 2028; it is estimated to record a CAGR of 8.2% from 2023 to 2028.

The US lymphedema treatment market growth is attributed to the rising incidence of lymphedema cases and increasing healthcare services and lymphedema management programs. However, a lack of awareness and skilled proffesionals is hampering the growth of the market.

Lymphedema involve the accumulation of lymph fluid in fatty tissues just beneath the skin. The condition is caused due to impaired flow in the lymphatic system of a person and is observed either in the legs or arms or in both. It can also be affecting abdomen, neck, genitals, and face of a person, depending on the portion of the body which has undergone treatment. Primary lymphedema is generally present at birth, while secondary lymphedema is caused due to dysfunction or damage to the lymphatic system.

According to the American College of Cardiology Foundation report, the treatment of lymphedema is primarily driven by symptom management, volume reduction, and infection prevention. For example, the first line of treatment for lymphedema is conservative management. Complete decongestive therapy (CGT) has become the forefront of physiotherapeutic conservative management. Additionally, surgical treatment approaches provide good adherence to conservative management. Moreover, the new minimally invasive vascularized lymph node transfer for lymphedema has gained significant attention worldwide. For example, physicians at Mayo Clinic's campus in Phoenix/Scottsdale, Arizona, have developed a new outpatient surgical procedure for patients experiencing lymphedema refractory to traditional therapy. Benefits associated with lymph node transfer involve a significant reduction of pain and swelling in the lymphedemic anatomy. Also, the surgery allows patients to decrease their antibiotic use, adding quality-of-life benefits among the patient pool. Further, patients diagnosed with breast, skin penile, bladder, and gynecological cancers may undergo lymph nodes procedure.

Lymphedema is a chronic, incurable disease affecting a patient's physical and mental well-being. Term-based care proves to be a multidisciplinary approach for patient management. The term-based care team includes people from physical rehabilitation, vascular medicine, plastic surgery, radiology, oncology, infectious disease, and social work. The team can provide a thorough evaluation for assessing the etiology of limb swelling, optimizing conservative care, and offering surgical treatment for appropriate candidates.

MedStar Health report states that a patient's lymphedema treatment plans will depend on the cause and severity of the condition. Doctors may prescribe medication or refer to a physical or occupational therapist specializing in the management of lymphedema. Therapies include reducing swelling and controlling pain through exercises, special massage techniques, or mechanical pumping devices. If a patient's condition is severe, doctors may recommend more advanced treatments such as lymph node transfer and lymphovenous bypass.

The Mayo Foundation for Medical Education and Research report states that the utility of robotics for lymphatic surgery allows much greater flexibility and precision compared to previously used laparoscopy. Additionally, the use of robotics proves optimal for both surgeon and patient outcomes and will reveal positive results during the forecast period. For instance, patients who underwent single-robotic surgery for lymphedema in May 2020 have provided positive anecdotal feedback, including significant clinical improvement such as the ability to wear clothes with the surgeon's significant accomplishments. Further, robots enabled with artificial intelligence (AI) are increasingly assisting in microsurgical procedures in lymphedema surgeries for reducing surgeon variations that could affect patient recovery. For example, for lymphedema surgery, in May 2020, an urogynecology surgeon performed a first-of-its-kind single-port robotic mental harvest by utilizing a free lymph node transfer, intended for minimally invasive surgical treatment of lymphedema. The main objective of this new surgical treatment method is to minimize donor site morbidity with debilitating lymphedema symptoms.

Treatment-Based Insights

Based on treatment, the US lymphedema treatment market is categorized into laser therapy, compression devices and bandaging, drug therapy, physiological procedures, debulking procedures, and others. The physiological procedures segment is further segmented into lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT). Similarly, the debulking procedures segment is subdivided into surgical debulking, liposuction, and others. The compression devices and bandaging segment held the largest share of the market in 2022. The physiological procedure segment is anticipated to register the highest CAGR during the forecast period mainly due to the treatment availability through LVA and VLNT performed on lymphedema patients. Two main physiologic interventions are currently incorporated to treat lymphedema. The primary intervention creates a shunt (a hole or a small passage to facilitate movement) between the congested lymphatic channels with the venous system close to the location of lymphatic obstruction. The other physiologic intervention incorporates vascularized soft tissue flaps that frequently include vascularized lymph nodes to the affected lymphatic extremity. Under this segment, the vascularized lymph node transfer (VLNT) procedure will grow at the highest CAGR% during the forecasted year. The Radiological Society of North America (RSNA) states that lymphedema treatment has traditionally been conservative and limited, but surgical and microsurgical procedures have risen tremendously today. For instance, VLNT is one of the most prominent and promising techniques for micro surgeries. VLNT involves the transfer of functional lymph nodes (LNs) from a healthy donor site to an area of the body with damaged or diseased lymphatic drainage.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Clinical Trial Imaging Market - by Modality
1.3.2 Global Clinical Trial Imaging Market - by Offering
1.3.3 Global Clinical Trial Imaging Market - by End User
1.3.4 Global Clinical Trial Imaging Market - by Geography
2. Clinical Trial Imaging Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Clinical Trial Imaging Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Expert Opinion
5. Clinical Trial Imaging Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Accelerated Clinical Trial Activities in Pharmaceutical and Biotechnology Industry
5.1.2 Spur in Number of CROs Offering Medical Imaging Services
5.2 Market Restraints
5.2.1 High Investment and Standardized Infrastructure Requirements
5.3 Market Opportunities
5.3.1 In-Silico Imaging Clinical Trials
5.4 Future Trends
5.4.1 AI-Driven Clinical Trials
5.5 Impact Analysis
6. Clinical Trial Imaging Market - Global Analysis
6.1 Global Clinical Trial Imaging Market Revenue Forecast and Analysis
6.2 Global Clinical Trial Imaging Market, by Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Clinical Trial Imaging Market Revenue and Forecast To 2028 - by Modality
7.1 Overview
7.2 Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
7.3 Tomography
7.3.1 Overview
7.3.2 Tomography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Ultrasound
7.4.1 Overview
7.4.2 Ultrasound: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Positron Emission Tomography
7.5.1 Overview
7.5.2 PET: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.6 X-Ray
7.6.1 Overview
7.6.2 X-Ray: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Echocardiography
7.7.1 Overview
7.7.2 Echocardiography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Magnetic Resonance Imaging
7.8.1 Overview
7.8.2 Magnetic Resonance Imaging: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.9 Others
7.9.1 Overview
7.9.2 Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8. Clinical Trial Imaging Market Revenue and Forecast To 2028 - Offering
8.1 Overview
8.2 Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
8.3 Trial Design Consulting Services
8.3.1 Overview
8.3.2 Trial Design Consulting Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Read Analysis Services
8.4.1 Overview
8.4.2 Read Analysis Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Operational Imaging Services
8.5.1 Overview
8.5.2 Operational Imaging Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Imaging Software
8.6.1 Overview
8.6.2 Imaging Software: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9. Clinical Trial Imaging Market Revenue and Forecasts To 2028- by End User
9.1 Overview
9.2 Clinical Trial Imaging Market Revenue Share, by End User (2022 and 2028)
9.3 Pharmaceutical and Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biopharmaceutical Companies: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Contract Research Organizations
9.4.1 Overview
9.4.2 Contract Research Organizations: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10. Clinical Trial Imaging Market - Revenue and Forecast to 2028 - Geographic Analysis
10.1 North America: Clinical Trial Imaging Market
10.1.1 Overview
10.1.2 North America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.1.4 North America: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.1.5 North America: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.1.6 North America: Clinical Trial Imaging Market, by Country, 2022& 2028 (%)
10.1.6.1 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.1.6.1.4 US: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.1.6.1.5 US: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.1.6.2 Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.3 Canada: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.1.6.2.4 Canada: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.1.6.2.5 Canada: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.1.6.3 Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.3 Mexico: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.1.6.3.4 Mexico: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.1.6.3.5 Mexico: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.2 Europe: Clinical Trial Imaging Market
10.2.1 Overview
10.2.2 Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.2.4 Europe: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.2.5 Europe: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.2.6 Europe: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
10.2.6.1 Germany: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 Germany: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.2.6.1.4 Germany: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.2.6.1.5 Germany: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.2.6.2 UK: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 UK: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 UK: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.2.6.2.4 UK: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.2.6.2.5 UK: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.2.6.3 France: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 France: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3 France: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.2.6.3.4 France: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.2.6.3.5 France: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.2.6.4 Italy: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3 Italy: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.2.6.4.4 Italy: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.2.6.4.5 Italy: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.2.6.5 Spain: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3 Spain: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.2.6.5.4 Spain: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.2.6.5.5 Spain: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.2.6.6 Rest of Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3 Rest of Europe: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.2.6.6.4 Rest of Europe: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.2.6.6.5 Rest of Europe: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.3 Asia Pacific: Clinical Trial Imaging Market
10.3.1 Overview
10.3.2 Asia Pacific: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.3.4 Asia Pacific: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.3.5 Asia Pacific: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.3.6 Asia Pacific: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
10.3.6.1 China: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.1 China: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.2 China: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.3.6.1.3 China: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.3.6.1.4 China: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.3.6.2 Japan: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Japan: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.2 Japan: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.3.6.2.3 Japan: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.3.6.2.4 Japan: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.3.6.3 India: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.1 India: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.2 India: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.3.6.3.3 India: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.3.6.3.4 India: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.3.6.4 South Korea: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.1 South Korea: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.2 South Korea: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.3.6.4.3 South Korea: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.3.6.4.4 South Korea: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.3.6.5 Australia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.1 Australia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.2 Australia: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.3.6.5.3 Australia: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.3.6.5.4 Australia: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Rest of Asia Pacific: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.2 Rest of Asia Pacific: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.4 South and Central America: Clinical Trial Imaging Market
10.4.1 Overview
10.4.2 South and Central America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.4.3 South and Central America: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.4.4 South and Central America: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.4.5 South and Central America: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.4.5.1 Brazil: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.4.5.1.1 Brazil: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.4.5.1.2 Brazil: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.4.5.1.3 Brazil: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.4.5.1.4 Brazil: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.4.5.2 Argentina: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.4.5.2.1 Argentina: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.4.5.2.2 Argentina: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.4.5.2.3 Argentina: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.4.5.2.4 Argentina: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.4.5.3 Rest of South and Central America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.4.5.3.1 Rest of South and Central America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.4.5.3.2 Rest of South and Central America: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.4.5.3.3 Rest of South and Central America: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.4.5.3.4 Rest of South and Central America: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.5 Middle East & Africa Clinical Trial Imaging Market
10.5.1 Overview
10.5.2 Middle East & Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.5.3 Middle East & Africa: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.5.4 Middle East & Africa: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.5.5 Middle East & Africa Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.5.6 Middle East & Africa: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
10.5.6.1 South Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.1 Overview
10.5.6.1.2 South Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3 South Africa: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.5.6.1.4 South Africa: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.5.6.1.5 South Africa Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.5.6.2 Saudi Arabia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.1 Overview
10.5.6.2.2 Saudi Arabia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3 Saudi Arabia: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.5.6.2.4 Saudi Arabia: Clinical Trial Imaging Market, by Product and Services, 2020-2028 (US$ Million)
10.5.6.2.5 Saudi Arabia Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.5.6.3 UAE: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.1 Overview
10.5.6.3.2 UAE: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.3 UAE: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.5.6.3.4 UAE: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.5.6.3.5 UAE Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.5.6.4 Rest of Middle East & Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.4.1 Overview
10.5.6.4.2 Rest of Middle East & Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.4.3 Rest of Middle East & Africa: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.5.6.4.4 Rest of Middle East & Africa: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.5.6.4.5 Rest of Middle East & Africa Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Clinical Trial Imaging Market
11.1 North America: Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 South and Central America: Impact Assessment of COVID-19 Pandemic
11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12. Clinical Trial Imaging Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies in Clinical Trial Imaging Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 eResearch Technology Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Calyx Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 ICON PLC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 VIDA Diagnostics Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 WCG Clinical Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioTelemetry Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Medical Metrics Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Medpace Holdings Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Radiant Sage LLC
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 IXICO plc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
List of Tables
Table 1. North America Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 4. US Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 5. US Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 6. US Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 13. Europe Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 14. Europe Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 16. Germany: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 17. Germany: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 18. Germany: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 19. UK Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 20. UK Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 21. UK Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 22. France: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 23. France: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 24. France: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 28. Spain: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 34. Asia Pacific Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 35. Asia Pacific Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 36. Asia Pacific Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 37. China Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 38. China Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 39. China Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 40. Japan Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 41. Japan Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 42. Japan Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 43. India Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 44. India Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 45. India Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 46. South Korea Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 47. South Korea Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 48. South Korea Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 49. Australia Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 50. Australia Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 51. Australia Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Asia Pacific Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Asia Pacific Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Asia Pacific Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 55. South and Central America Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 56. South and Central America Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 57. South and Central America Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 58. Brazil Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 59. Brazil Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 60. Brazil Clinical Trial Imaging Market, by End Use- Revenue and Forecast to 2028 (US$ Million)
Table 61. Argentina Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 62. Argentina Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 63. Argentina Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 64. Rest of South and Central America Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 65. Rest of South and Central America Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 66. Rest of South and Central America Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 67. Middle East & Africa Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 68. Middle East & Africa Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 69. Middle East & Africa Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 70. South Africa Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 71. South Africa Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 72. South Africa Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 73. Saudi Arabia Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 74. Saudi Arabia Clinical Trial Imaging Market, by Product and Services - Revenue and Forecast to 2028 (US$ Million)
Table 75. Saudi Arabia Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 76. UAE Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 77. UAE Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 78. UAE Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 79. Rest of Middle East & Africa Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 80. Rest of Middle East & Africa Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 81. Rest of Middle East & Africa Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 82. Recent Inorganic Growth Strategies in the Clinical Trial Imaging Market
Table 83. Recent Organic Growth Strategies in Clinical Trial Imaging Market
Table 84. Glossary of Terms
List of Figures
Figure 1. Clinical Trial Imaging Market Segmentation
Figure 2. Clinical Trial Imaging Market by Region
Figure 3. Global Clinical Trial Imaging Market Overview
Figure 4. Tomography Largest Share of Modality Segment in Clinical Trial Imaging Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Clinical Trial Imaging Market, by Geography (US$ Million)
Figure 7. Global Clinical Trial Imaging Market - Leading Country Markets (US$ Million)
Figure 8. Global Clinical Trial Imaging Market - Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Clinical Trial Imaging Market: Impact Analysis of Drivers and Restraints
Figure 15. Global Clinical Trial Imaging Market - Revenue Forecast and Analysis - 2021-2028
Figure 16. Global Clinical Trial Imaging Market, by Geography - Forecast and Analysis (2022-2028)
Figure 17. Market Positioning of Key Players in the Clinical Trial Imaging Market
Figure 18. Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
Figure 19. Tomography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ultrasound: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. PET: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. X-Ray: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Echocardiography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Magnetic Resonance Imaging: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
Figure 27. Trial Design Consulting Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Read Analysis Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Operational Imaging Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Imaging Software: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Clinical Trial Imaging Market Revenue Share, by End User (2022 and 2028)
Figure 33. Pharmaceutical and Biopharmaceutical Companies: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Contract Research Organizations: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Academic and Research Institutes: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. North America: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
Figure 38. North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. North America: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
Figure 40. US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 43. Europe: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
Figure 44. Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. Europe: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
Figure 46. Germany: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. UK: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. France: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 49. Italy: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. Spain: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 51. Rest of Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 52. Asia Pacific: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
Figure 53. Asia Pacific Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 54. China Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 55. Japan Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 56. India Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 57. South Korea Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 58. Australia Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 59. Rest of Asia Pacific Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 60. South and Central America: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
Figure 61. South and Central America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 62. Brazil Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 63. Argentina Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 64. Rest of South and Central America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 65. Middle East & Africa: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
Figure 66. Middle East & Africa Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 67. South Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 68. Saudi Arabia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 69. UAE: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 70. Rest of Middle East & Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 71. Impact of COVID-19 Pandemic on North American Country Markets
Figure 72. Impact of COVID-19 Pandemic on European Country Markets
Figure 73. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
Figure 74. Impact of COVID-19 Pandemic on South and Central America Country Markets
Figure 75. Impact of COVID-19 Pandemic on Middle East and Africa Country Markets
Figure 76. Growth Strategies in Clinical Trial Imaging Market

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Biocompression Systems
  • Tactile Medical
  • Smith & Nephew
  • Essity Ab
  • Lohmann & Rauscher GmbH & Co. Kg
  • Sigvaris Group
  • Thermotek
  • Huntleigh Healthcare Limited
  • 3M
  • Airos Medical, Paul Hartmann Ag

Table Information

Report AttributeDetails
No. of Pages132
PublishedMay 2023
Forecast Period2023 - 2028
Estimated Market Value ( USD ) in 2023 $ 5185.98 Million
Forecasted Market Value ( USD ) by 2028 $ 8320.07 Million
Compound Annual Growth Rate8.2%
Regions CoveredUnited States

Related Topics

Related Reports

Lymphedema Treatment Instrument Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028 - Product Image

Lymphedema Treatment Instrument Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028

  • Report
  • 171 Pages
  • Global
From
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) - Market Insights, Epidemiology, and Market Forecast - 2032 - Product Image

Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) - Market Insights, Epidemiology, and Market Forecast - 2032

  • Report
  • 175 Pages
  • Global
From
Ulcerative Colitis (UC) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Image

Ulcerative Colitis (UC) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • 295 Pages
  • Global
From
Global CD3 Antibodies Market, Dosage, Price, Sales & Clinical Trials Insight 2028 - Product Image

Global CD3 Antibodies Market, Dosage, Price, Sales & Clinical Trials Insight 2028

  • Report
  • 470 Pages
  • Global
From
Systemic Juvenile Idiopathic Arthritis Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028 - Product Image

Systemic Juvenile Idiopathic Arthritis Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028

  • Report
  • 181 Pages
  • Global
From

About the Lymphedema Drug Market

The Lymphedema Drug market is a subset of the Immune Disorders Drugs market. Lymphedema is a chronic condition caused by a build-up of lymph fluid in the body's tissues, leading to swelling. Lymphedema drugs are used to reduce swelling and improve the quality of life of those affected. These drugs are typically administered through injections, topical creams, and oral medications. Lymphedema drugs are often used in combination with other treatments such as physical therapy, compression garments, and exercise. The Lymphedema Drug market is highly competitive, with a range of companies offering products to treat the condition. Some of the major players in the market include Pfizer, Sanofi, Novartis, and Allergan. Other companies in the market include Merck, Johnson & Johnson, and Bayer. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.